1,214 results match your criteria: "Ohashi Medical Center[Affiliation]"

Article Synopsis
  • Total elbow arthroplasty (TEA) is an effective treatment for painful, deformed elbow joints, but it has a high rate of complications, particularly using unlinked designs like the Kudo prosthesis in Japan.
  • Recent advancements in surgical techniques and support devices aim to improve patient outcomes, with studies showing favorable long-term results despite ongoing complications such as infections and structural failures.
  • Japanese innovations include the triceps-on surgical approach for better tendon preservation, and the use of advanced 3D preoperative planning to enhance implant fitting and placement.
View Article and Find Full Text PDF

Malignant colonic obstruction can cause necrosis, bacterial translocation, electrolytic imbalance, and death; therefore, immediate decompression should be performed. Self-expandable metallic colonic stents are an established treatment for the decompression of malignant colonic obstructions. The use of stents that open from the distal side, which have been commonly used until now, requires caution because placing a stent on the dentate line can cause severe pain, and there is a possibility of cutting the stent during rectal resection of the distal side of the tumor.

View Article and Find Full Text PDF

Objectives: To investigate factors associated with symptomatic urinary tract infection (sUTI) in persons with chronic spinal cord lesion (SCL) who were using single-use catheters for intermittent self-catheterization (ISC).

Methods: Among respondents to an internet survey on the burden of illness on persons with SCL who were considered to be able to perform ISC, 111 persons using single-use catheters were included to examine factors associated with self-reported sUTI by univariate as well as multivariable analysis.

Results: The incidence of sUTI was significantly higher in males than in females (56.

View Article and Find Full Text PDF

Background:  Real-world data on clinical characteristics and outcomes related to the use of different direct oral anticoagulants (DOACs) for cancer-associated venous thromboembolism (VTE) is lacking.

Methods:  The COMMAND VTE Registry-2 is a multicenter registry enrolling 5,197 consecutive patients with acute symptomatic VTE from 31 centers in Japan from January 2015 to August 2020. Our study population comprised 1,197 patients with active cancer who were divided into the edoxaban ( = 643, 54%), rivaroxaban ( = 297, 25%), and apixaban ( = 257, 22%) groups.

View Article and Find Full Text PDF
Article Synopsis
  • A study analyzed the incidence of taste disorders and alopecia in 1,710 myasthenia gravis (MG) patients, revealing 6.1% had taste issues and 8.2% experienced hair loss.
  • Taste disorders were more common in women and those with severe or thymoma-associated MG, often appearing after MG onset and responding to treatments.
  • Alopecia was linked to patients with bulbar palsy and thymoma, frequently occurring before MG onset and sometimes responding to treatment, highlighting the need for clinicians to recognize these non-motor symptoms in severe MG cases.
View Article and Find Full Text PDF
Article Synopsis
  • Direct oral anticoagulants (DOACs) are commonly used for treating venous thromboembolism in cancer patients, yet they can lead to bleeding complications, particularly in those with gastrointestinal (GI) cancers.
  • A study analyzed data from 1,149 cancer patients on DOACs to assess bleeding outcomes, showing that those with upper GI cancer had a higher incidence of major bleeding (22.4%) compared to those with lower GI (15.4%) and non-GI cancers (11.6%).
  • The research concluded that upper GI cancer significantly increases the risk of major bleeding during anticoagulation therapy, unlike lower GI cancer, which had no significant difference in bleeding risk compared to non-GI cancers.
View Article and Find Full Text PDF

Purpose: Some patients refrained from seeking an ophthalmologist due to the anxiety and morbidity associated with the coronavirus disease (COVID-19) pandemic. We investigated progressive visual field defects in patients with glaucoma who refrained from ophthalmological examinations.

Methods: This was a retrospective study.

View Article and Find Full Text PDF
Article Synopsis
  • Researchers studied unprovoked venous thromboembolisms (VTEs) in a large registry to identify distinct patient phenotypes using latent class analysis (LCA).
  • The study classified patients into three subgroups based on age and health conditions: younger patients, older patients with few comorbidities, and older patients with many comorbidities.
  • Findings revealed differences in treatment outcomes, with higher anticoagulation discontinuation and bleeding risks in older patients with more comorbidities, suggesting tailored management strategies could improve patient care.
View Article and Find Full Text PDF
Article Synopsis
  • The ONCO DVT study showed that a 12-month treatment with edoxaban is more effective than a 3-month treatment for preventing blood clots in patients with cancer-associated isolated distal deep vein thrombosis (DVT).
  • In a subgroup analysis, both standard (60 mg/day) and reduced (30 mg/day) dosages of edoxaban had lower rates of recurrent blood clots in those treated for 12 months compared to 3 months, but the risk of major bleeding was higher for the standard dose over 12 months.
  • Overall, while a longer duration of edoxaban treatment is beneficial for reducing thrombotic risk, there is a cautionary note about increased bleeding risks with the higher dosage over extended periods
View Article and Find Full Text PDF

Background: Myasthenia gravis (MG) is an immune disorder that causes muscle weakness with an increasing prevalence, particularly among the elderly in Japan. Glucocorticoid treatment for MG is problematic for bone health because of reduced bone density and increased fracture risk. The fracture risk assessment tool (FRAX®) can estimate fracture risk, but its applicability in patients with MG remains uncertain.

View Article and Find Full Text PDF
Article Synopsis
  • The CLOT-COVID Study analyzed 2894 hospitalized patients with COVID-19, focusing on 1738 patients with mild cases who didn’t need oxygen at admission.
  • Patients were split into two groups: those receiving prophylactic anticoagulation (326 patients) and those who were not (1412 patients).
  • Results showed that those on anticoagulation had higher severity levels during hospitalization and a slightly higher incidence of thrombosis, suggesting that routine use may not be beneficial for all stable patients.
View Article and Find Full Text PDF

Laparoscopic deroofing (LD) for giant liver cysts using indocyanine green (ICG) fluorescence imaging was performed in two patients: a 53-year-old man with a 26-cm, symptomatic cyst and a 50-year-old woman with a 13-cm, symptomatic cyst. ICG fluorescence imaging can be used to easily identify the boundary between the liver parenchyma and the liver cyst. No postoperative bile leakage was observed in both patients.

View Article and Find Full Text PDF

Objectives: To report up to 3-year safety and effectiveness of certolizumab pegol (CZP) in Japanese patients with rheumatoid arthritis from a postmarketing surveillance study.

Methods: Patients enrolled previously completed 24 weeks of CZP in the 24-week postmarketing surveillance study. Adverse drug reactions (ADRs) were recorded for patients who received ≥1 CZP dose.

View Article and Find Full Text PDF

This study compared magnetic resonance imaging (MRI) findings of postmortem brain specimens with neuropathological findings to evaluate the value of postmortem MRI. Postmortem MRI was performed on five formalin-fixed whole brains with malignant tumors. Postmortem T2-weighted images detected all neuropathological abnormalities as high-signal regions but also showed histological tumor invasion in areas without edema.

View Article and Find Full Text PDF

Background: Despite an increased incidence of chronic heart failure (HF) and sudden cardiac death (SCD), the use of implantable cardioverter-defibrillators (ICDs) and cardiac resynchronization therapy (CRT) is much lower in Japan than in Western countries. The HF Indication and SCD Prevention Trial Japan (HINODE) prospectively assessed the mortality rate, appropriately treated ventricular arrhythmias (VA), and HF in Japanese patients with a higher risk of HF.

Methods and results: HINODE consisted of ICD, CRT-defibrillator (CRT-D), pacing, and non-device treatment cohorts.

View Article and Find Full Text PDF

Pouchitis is the most common long-term complication following ileal pouch-anal anastomosis (IPAA) in patients with ulcerative colitis. Although several agents, including probiotics, steroids, and immunomodulators, have been used, the treatment of pouchitis remains challenging. Owing to the proven efficacy of biological therapy in inflammatory bowel disease, there is now growing evidence suggesting the potential benefits of biological therapy in refractory pouchitis.

View Article and Find Full Text PDF

Purpose: To retrospectively evaluate the 3-year efficacy and safety of single-agent omidenepag isopropyl in patients with normal tension glaucoma (NTG).

Study Design: Retrospective.

Methods: One hundred patients (100 eyes) who had newly been administered omidenepag isopropyl were enrolled in this study.

View Article and Find Full Text PDF
Article Synopsis
  • Eculizumab and ravulizumab are effective treatments for patients with anti-acetylcholine receptor-positive generalized myasthenia gravis, showing good results in both clinical trials and real-world experiences.
  • In a study of 1,106 patients, 36 received eculizumab, leading to significant clinical improvement for the majority, with 70% showing a positive response.
  • Patients switching to ravulizumab reported continued effectiveness and a preference for ravulizumab over eculizumab, indicating it may be a favorable option for ongoing treatment.
View Article and Find Full Text PDF
Article Synopsis
  • The AFIRE trial showed that rivaroxaban alone is as effective as rivaroxaban with an antiplatelet in patients with atrial fibrillation and stable coronary artery disease, while being safer.
  • A post hoc analysis revealed that the benefits of rivaroxaban monotherapy were particularly significant in patients who had previously undergone revascularisation.
  • For those without prior revascularisation, there was no notable difference in efficacy, although there was a significant safety advantage for monotherapy concerning bleeding risks.
View Article and Find Full Text PDF
Article Synopsis
  • Tumor-treating fields (TTFields) is a recognized treatment for glioblastoma, but can lead to delayed pseudoprogression, which is often confused with actual tumor progression.
  • The report discusses two cases of patients with glioblastoma experiencing this delayed response, showing radiographic signs of progression six months post-radiation therapy.
  • In both cases, further investigations revealed these signs were due to treatment effects rather than actual disease progression, highlighting the need for more research to understand this phenomenon.
View Article and Find Full Text PDF

Therapeutic Responses to Efgartigimod for Generalized Myasthenia Gravis in Japan.

Neurol Clin Pract

June 2024

Department of Neurology (SS, KI, DT), Keio University School of Medicine, Tokyo; Department of Neurology (AU, HH, MY), Graduate School of Medicine, Chiba University; Department of Neurology (YN, KU), Hanamaki General Hospital; Department of Neurology (MM), Tokyo Medical University; Department of Neurology (SK), Toho University Ohashi Medical Center, Tokyo; Division of Health Sciences (T. Kubota, MPT), Department of Clinical Laboratory and Biomedical Sciences, Osaka University Graduate School of Medicine; Department of Neurology (MS), Kindai University Faculty of Medicine, Sayama; Department of Neurology (NK), Neurology Chiba Clinic; Department of Neurology (T. Kimura), Hyogo Medical University, Nishinomiya; Department of Neurology (YS), National Hospital Organization Sendai Medical Center, Sendai; Department of Clinical Neuroscience and Therapeutics (TS), Hiroshima University; Department of Neurology (NM), National Hospital Organization Hokkaido Medical Center, Sapporo; and Department of Neurology (HM), International University of Health and Welfare, Narita, Japan.

Article Synopsis
  • Efgartigimod is a treatment for generalized myasthenia gravis (MG) available in Japan, effective for various forms of the disease, including AChR+, MuSK+, and seronegative types.
  • A study involving 1,343 patients found that 36 (2.7%) started efgartigimod, with significant improvements in daily living activities, overall MG symptoms, and quality of life following treatment cycles.
  • The majority of patients (62%) responded positively to the first treatment cycle, although the duration of effectiveness varied, with some responders needing only a single effective cycle.
View Article and Find Full Text PDF
Article Synopsis
  • - Prolactin-secreting pituitary neuroendocrine tumors (PitNETs) are more prevalent in women, but in men, these tumors can present with few symptoms and larger sizes extending beyond the sella turcica.
  • - A study of nine male patients (ages 26-65) with these tumors found that high prolactin levels (average of 2734.6 ng/mL) and tumor sizes (average diameter of 40.4 mm) were common. Symptoms included visual disturbances (44.4%) and headaches (33.3%).
  • - After treatment with cabergoline, eight out of nine patients experienced reduction in prolactin levels and tumor size, indicating caberg
View Article and Find Full Text PDF
Article Synopsis
  • - A nationwide survey in Japan in 2023 found that 77.9% of participants aged 20 and older reported lower urinary tract symptoms (LUTS), with prevalence increasing to 82.5% among those 40 and older.
  • - The study included 6,210 participants (3088 females and 3122 males) and revealed that conditions like overactive bladder (OAB) affected 11.9% of the younger age group (≥20) and 13.8% of those 40 and older.
  • - Despite the high prevalence and negative impact of LUTS on daily life, few participants sought medical treatment, highlighting the need for increased awareness and education on the subject.
View Article and Find Full Text PDF

Background: The 1-year clinical outcomes of the Absorb GT1 Japan post-market surveillance (PMS) suggested that an appropriate intracoronary imaging-guided bioresorbable vascular scaffold (BVS) implantation technique may reduce the risk of target lesion failure (TLF) and scaffold thrombosis (ST) associated with the Absorb GT1 BVS. The long-term outcomes through 5 years are now available.

Methods and results: This study enrolled 135 consecutive patients (n=139 lesions) with ischemic heart disease in whom percutaneous coronary intervention (PCI) with the Absorb GT1 BVS was attempted.

View Article and Find Full Text PDF